title: Flt-3 and its ligand are expressed in neural crest-derived tumors and promote survival and proliferation of their cell lines.
abstract: Flt-3 ligand (FL) is a cytokine that promotes the survival, proliferation, and differentiation of hematopoietic progenitors in synergy with other growth factors, such as stem cell factor. Previously we have demonstrated that stem cell factor and its receptor c-kit are expressed in neural crest-derived tumor cells and that a c-kit block induces their apoptosis. Here we have evaluated the expression of flt-3 and its ligand in 12 neuroectodermal tumor cell lines from neuroblastoma (NB), neuroepithelioma (NE), Ewing sarcoma (ES), and peripheral neuroectodermal tumor (PNET) and in 38 biopsies: 19 from NB and 19 from ES and PNET. RT-PCR demonstrated the expression of flt-3 and FL in all lines. Coexpression was observed in 42% of NB and in 74% of ES and PNET biopsies. Flow cytometry confirmed the presence of membrane and cytoplasmic flt-3 and membrane FL in all lines, whereas soluble FL protein was not measurable in their supernatants. Microphysiometric demonstration of acidification of the medium provided evidence of the specific response of cell lines to FL stimulation. Specific flt-3 phosphorylation after FL treatment was also demonstrated by Western blotting analysis. In cells growing in RPMI plus 1% fetal calf serum, FL revealed a significant proliferating activity, more evident in NB and NE lines (mean increase of viable cells, 73 +/- 26% after 1 day). Treatment with flt-3 antisense oligonucleotides significantly inhibited cell growth. FL also displayed an antiapoptotic activity: after a 12-hour culture in the presence of 0.1% fetal calf serum, FL caused a 50% reduction of apoptotic cells. These results provide further evidence that neuroectodermal and hematopoietic cells share common regulatory pathways, and could be of interest in the clinical management of neuroectodermal tumors.
authors.affiliation: Department of Pediatrics, University of Torino, Turin, Italy. timeus@pediatria.unito.it
authors.forename: F
authors.initials: F
authors.lastname: Timeus
authors.forename: E
authors.initials: E
authors.lastname: Ricotti
authors.forename: N
authors.initials: N
authors.lastname: Crescenzio
authors.forename: E
authors.initials: E
authors.lastname: Garelli
authors.forename: A
authors.initials: A
authors.lastname: Doria
authors.forename: M
authors.initials: M
authors.lastname: Spinelli
authors.forename: U
authors.initials: U
authors.lastname: Ramenghi
authors.forename: G
authors.initials: G
authors.lastname: Basso
mesh_terms: D001483:Base Sequence; D002455:Cell Division; D002460:Cell Line; D002470:Cell Survival; D017931:DNA Primers; D005434:Flow Cytometry; D006801:Humans; D008024:Ligands; D008565:Membrane Proteins / Q000235:genetics* / Q000378:metabolism; D009423:Nervous System Neoplasms / Q000378:metabolism* / Q000473:pathology; D009432:Neural Crest / Q000473:pathology*; D011518:Proto-Oncogene Proteins / Q000235:genetics* / Q000378:metabolism; D020794:Receptor Protein-Tyrosine Kinases / Q000235:genetics* / Q000378:metabolism; D020133:Reverse Transcriptase Polymerase Chain Reaction; D051941:fms-Like Tyrosine Kinase 3
chemical_list: D017931:DNA Primers; D008024:Ligands; D008565:Membrane Proteins; D011518:Proto-Oncogene Proteins; C084881:flt3 ligand protein; C497970:FLT3 protein, human; D020794:Receptor Protein-Tyrosine Kinases; D051941:fms-Like Tyrosine Kinase 3